Literature DB >> 8548705

Abortion induced with methotrexate and misoprostol.

E R Wiebe1.   

Abstract

OBJECTIVE: To determine the outcome and side effects of a new drug protocol to induce abortion.
DESIGN: Case series.
SETTING: An urban primary care practice. PATIENTS: One hundred consecutive patients who requested elective termination of pregnancies of less than 8 weeks' gestation. INTERVENTION: Subjects received methotrexate (50 mg/m2 body surface area, administered intramuscularly) and, 3 days afterward, misoprostol (800 micrograms, given vaginally). OUTCOME MEASURES: Number of abortions induced within 24 hours and within 10 days of misoprostol administration, number of surgical aspirations conducted because of incomplete abortion, mean amount of bleeding and pain and the number of women who, if faced with the same situation, said they would again choose a drug-induced abortion over a surgical one.
RESULTS: Abortion occurred within 24 hours of misoprostol administration among 48 women and within 10 days among 69 women. In total, 89 women had an abortion without surgical aspiration. Of these women, 71 said they would choose a drug-induced abortion if faced with the choice again.
CONCLUSION: Abortion induced with methotrexate and misoprostol appears to be a feasible alternative to surgical abortion and deserves further study.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8548705      PMCID: PMC1488147     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  23 in total

1.  Teratogenicity of misoprostol.

Authors:  L Schüler; P W Ashton; M T Sanseverino
Journal:  Lancet       Date:  1992-02-15       Impact factor: 79.321

2.  Medical abortion.

Authors:  P Doherty
Journal:  BMJ       Date:  1992-02-29

3.  Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion.

Authors:  D R Urquhart; A A Templeton
Journal:  Br J Obstet Gynaecol       Date:  1991-04

4.  A pilot study of acceptability of RU486 and ONO 802 in a Chinese population.

Authors:  G W Tang
Journal:  Contraception       Date:  1991-11       Impact factor: 3.375

5.  Reproductive performance after methotrexate treatment of ectopic pregnancy.

Authors:  T G Stovall; F W Ling; J E Buster
Journal:  Am J Obstet Gynecol       Date:  1990-06       Impact factor: 8.661

6.  Methotrexate-induced congenital malformations.

Authors:  H R Powell; H Ekert
Journal:  Med J Aust       Date:  1971-11-20       Impact factor: 7.738

7.  Congenital anomalies among children born of mothers receiving chemotherapy for gestational trophoblastic neoplasms.

Authors:  G T Ross
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

8.  Single-dose methotrexate for treatment of ectopic pregnancy.

Authors:  T G Stovall; F W Ling; L A Gray
Journal:  Obstet Gynecol       Date:  1991-05       Impact factor: 7.661

Review 9.  Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease.

Authors:  R D Kozlowski; J V Steinbrunner; A H MacKenzie; J D Clough; W S Wilke; A M Segal
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

10.  A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion.

Authors:  M D Creinin; E Vittinghoff; S Galbraith; C Klaisle
Journal:  Am J Obstet Gynecol       Date:  1995-11       Impact factor: 8.661

View more
  4 in total

1.  Reducing surgery in management of spontaneous abortions. Family physicians can make a difference.

Authors:  E Wiebe; P Janssen
Journal:  Can Fam Physician       Date:  1999-10       Impact factor: 3.275

2.  Medical abortion and family physicians. Survey of residents and practitioners in two Ontario settings.

Authors:  Elin Raymond; Janusz Kaczorowski; Pat Smith; John Sellors; Allyn Walsh
Journal:  Can Fam Physician       Date:  2002-03       Impact factor: 3.275

3.  Formulation and in vitro characterization of xanthan gum-based sustained release matrix tables of isosorbide-5- mononitrate.

Authors:  Rajat Kar; Snehamayee Mohapatra; Satyabrata Bhanja; Debjyoti Das; Bhaktibhusan Barik
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

4.  Misoprostol alone or in combination with methotrexate for termination of pregnancy at first trimester.

Authors:  Fatemeh Vahid Roudsari; Sedigheh Ayati; Nafiseh Saghafy; Mohamadtaghi Shakeri
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.